中国成人血浆β-淀粉样蛋白40和42浓度与2型糖尿病的关联
研究在中国成人中开展病例对照研究和前瞻性队列嵌套病例对照研究,采用电化学发光免疫分析法检测血浆Aβ40和Aβ42浓度,用条件logistic回归评估其与2型糖尿病风险的关联。结果显示血浆Aβ40和Aβ42浓度升高与2型糖尿病风险呈正相关,但需进一步研究阐明机制。
要点
- 病例对照研究中,血浆Aβ40最高四分位组较最低四分位组2型糖尿病OR为1.97(95%CI 1.46, 2.66)。
- 病例对照研究中,血浆Aβ42最高四分位组较最低四分位组2型糖尿病OR为2.01(95%CI 1.50, 2.69)。
- Aβ40和Aβ42均处于最高三分位组者较均处于最低三分位组者2型糖尿病OR为2.96倍。
核心结论
- 研究提示血浆Aβ40和Aβ42浓度与2型糖尿病风险呈正相关。
- 需进一步研究阐明潜在机制并探索血浆Aβ在连接2型糖尿病与阿尔茨海默病中的潜在作用。
研究设计与样本
- 病例对照研究纳入1063例新诊断2型糖尿病患者和1063名按年龄(±3岁)和性别匹配的对照。
- 前瞻性队列嵌套病例对照研究纳入121例新发2型糖尿病患者和242名匹配对照。
- 采用电化学发光免疫分析法同时检测血浆Aβ40和Aβ42浓度,用条件logistic回归评估关联。
主要发现
- 病例对照研究:血浆Aβ40最高四分位组较最低四分位组2型糖尿病多变量调整OR为1.97(95%CI 1.46, 2.66),Aβ42为2.01(95%CI 1.50, 2.69)。
- 病例对照研究:血浆Aβ40每增加30 ng/l与2型糖尿病 odds 升高28%(95%CI 15%, 43%)相关,Aβ42每增加5 ng/l与 odds 升高37%(95%CI 21%, 55%)相关。
- 病例对照研究:血浆Aβ40和Aβ42均处于最高三分位组者较均处于最低三分位组者2型糖尿病 odds 为2.96倍。
- 嵌套病例对照研究:血浆Aβ40最高四分位组较最低四分位组2型糖尿病多变量调整OR为3.79(95%CI 1.81, 7.94),Aβ42为2.88(95%CI 1.44, 5.75)。
- 嵌套病例对照研究:血浆Aβ40每增加30 ng/l与2型糖尿病多变量调整OR为1.44(95%CI 1.18, 1.74),Aβ42每增加5 ng/l为1.47(95%CI 1.15, 1.88)。
局限性
- 需进一步研究阐明潜在机制并探索血浆Aβ在连接2型糖尿病与阿尔茨海默病中的潜在作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: There is evidence for a bidirectional association between type 2 diabetes and Alzheimer's disease. Plasma β-amyloid (Aβ) is a potential biomarker for Alzheimer's disease. We aimed to investigate the association of plasma Aβ40 and Aβ42 with risk of type 2 diabetes. METHODS: We performed a case-control study and a nested case-control study within a prospective cohort study. In the case-control study, we included 1063 newly diagnosed individuals with type 2 diabetes and 1063 control participants matched by age (±3 years) and sex. In the nested case-control study, we included 121 individuals with incident type 2 diabetes and 242 matched control individuals. Plasma Aβ40 and Aβ42 concentrations were simultaneously measured with electrochemiluminescence immunoassay. Conditional logistic regression was used to evaluate the association of plasma Aβ40 and Aβ42 concentrations with the likelihood of type 2 diabetes. RESULTS: In the case-control study, the multivariable-adjusted ORs for type 2 diabetes, comparing the highest with the lowest quartile of plasma Aβ concentrations, were 1.97 (95% CI 1.46, 2.66) for plasma Aβ40 and 2.01 (95% CI 1.50, 2.69) for plasma Aβ42. Each 30 ng/l increment of plasma Aβ40 was associated with 28% (95% CI 15%, 43%) higher odds of type 2 diabetes, and each 5 ng/l increment of plasma Aβ42 was associated with 37% (95% CI 21%, 55%) higher odds of type 2 diabetes. Individuals in the highest tertile for both plasma Aβ40 and Aβ42 concentrations had 2.96-fold greater odds of type 2 diabetes compared with those in the lowest tertile for both plasma Aβ40 and Aβ42 concentrations. In the nested case-control study, the multivariable-adjusted ORs for type 2 diabetes for the highest vs the lowest quartile were 3.79 (95% CI 1.81, 7.94) for plasma Aβ40 and 2.88 (95% CI 1.44, 5.75) for plasma Aβ42. The multivariable-adjusted ORs for type 2 diabetes associated with each 30 ng/l increment in plasma Aβ40 and each 5 ng/l increment in plasma Aβ42 were 1.44 (95% CI 1.18, 1.74) and 1.47 (95% CI 1.15, 1.88), respectively. CONCLUSIONS/INTERPRETATION: Our findings suggest positive associations of plasma Aβ40 and Aβ42 concentration with risk of type 2 diabetes. Further studies are warranted to elucidate the underlying mechanisms and explore the potential roles of plasma Aβ in linking type 2 diabetes and Alzheimer's disease.
引用
- Peng X, Xu Z, Mo X, et al. Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults. Diabetologia. 2020. PMID: 32034441. doi:10.1007/s00125-020-05102-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。